Skip to main content


Fig. 2 | BMC Neurology

Fig. 2

From: Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy

Fig. 2

Effect of dapagliflozin on EEG tracing. The addition of dapagliflozin at 75 mg/kg IP (row c) and 150 mg/kg IP (row d) resulted in fewer epileptiform activity as compared to no dapagliflozin (row b) in rats treated with 35 mg/kg of IP pentylenetetrazol (PTZ). Row a is a vehicle-treated (placebo) group that received neither PTZ nor dapagliflozin

Back to article page